Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The European Society for Medical Oncology (ESMO)

The European Society for Medical Oncology (ESMO) ABSTRACTS INTRODUCTION he European Society for Medical Oncology (ESMO) is the leading European professional organization, committed to advanc- T ing the specialty of medical oncology and promoting a multidisciplinary approach to cancer treatment and care. Since its founding in 1975 as a non-profit organization, ESMO’s mission has been to advance cancer care and cure. We achieve this through fostering and disseminating good science that leads to better medicine and determines best practice. In this way ESMO fulfils its goal to support oncology professionals in providing people with cancer with the most effective treatments available and the high-quality care they deserve. The ESMO community is a powerful alliance of more than 7,000 committed oncology professionals from over 120 countries. As a trusted organization with 35 years of experience and over 500 expert committee members, ESMO serves its members and the oncology community through: •  Excellence in post-graduate oncology education and training •  Leadership in transforming evidence-based research into standards of cancer care in Europe •  Dedicated efforts to foster a more favorable environment for scientific research •  Innovative international platforms to share expertise, best practices and disseminate the most up-to-date scientific research to as wide an audience as possible. ESMO has expanded its membership offering through OncologyPRO, an exclusive scientific and educational website: http:\\ oncologypro.esmo.org. ESMO’s scientic fi journal, Annals of Oncology, ranks among the top clinical oncology journals worldwide. ESMO events are the meeting place in Europe for medical oncologists to update their knowledge, network and exchange ideas. ESMO also unites key oncology stakeholders and forges strategic partnerships to address critical issues related to the profession and practice of medical oncology. Recognized as an authoritative voice in the fight against cancer, ESMO is pleased to offer consultative expertise to oncology organizations and European authorities on important issues related to cancer research, prevention, diagnosis, treatment and care. Join the ESMO community today! Please visit www.esmo.org to learn more. European Society for Medical Oncology (ESMO) Via Luigi Taddei, 4, 6962 Viganello – Lugano, Switzerland T +41 (0)91 973 19 00 F +41 (0)91 973 19 02 W www.esmo.org E esmo@esmo.org S2 Journal of Thoracic Oncology • Volume 7, Number 6, Supplement 1, June 2012 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

The European Society for Medical Oncology (ESMO)

Journal of Thoracic Oncology , Volume 7 – Jun 1, 2012
Download PDF
1 page

Loading next page...
 
/lp/wolters-kluwer-health/the-european-society-for-medical-oncology-esmo-Q0E8vytyjw

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864

Abstract

ABSTRACTS INTRODUCTION he European Society for Medical Oncology (ESMO) is the leading European professional organization, committed to advanc- T ing the specialty of medical oncology and promoting a multidisciplinary approach to cancer treatment and care. Since its founding in 1975 as a non-profit organization, ESMO’s mission has been to advance cancer care and cure. We achieve this through fostering and disseminating good science that leads to better medicine and determines best practice. In this way ESMO fulfils its goal to support oncology professionals in providing people with cancer with the most effective treatments available and the high-quality care they deserve. The ESMO community is a powerful alliance of more than 7,000 committed oncology professionals from over 120 countries. As a trusted organization with 35 years of experience and over 500 expert committee members, ESMO serves its members and the oncology community through: •  Excellence in post-graduate oncology education and training •  Leadership in transforming evidence-based research into standards of cancer care in Europe •  Dedicated efforts to foster a more favorable environment for scientific research •  Innovative international platforms to share expertise, best practices and disseminate the most up-to-date scientific research to as wide an audience as possible. ESMO has expanded its membership offering through OncologyPRO, an exclusive scientific and educational website: http:\\ oncologypro.esmo.org. ESMO’s scientic fi journal, Annals of Oncology, ranks among the top clinical oncology journals worldwide. ESMO events are the meeting place in Europe for medical oncologists to update their knowledge, network and exchange ideas. ESMO also unites key oncology stakeholders and forges strategic partnerships to address critical issues related to the profession and practice of medical oncology. Recognized as an authoritative voice in the fight against cancer, ESMO is pleased to offer consultative expertise to oncology organizations and European authorities on important issues related to cancer research, prevention, diagnosis, treatment and care. Join the ESMO community today! Please visit www.esmo.org to learn more. European Society for Medical Oncology (ESMO) Via Luigi Taddei, 4, 6962 Viganello – Lugano, Switzerland T +41 (0)91 973 19 00 F +41 (0)91 973 19 02 W www.esmo.org E esmo@esmo.org S2 Journal of Thoracic Oncology • Volume 7, Number 6, Supplement 1, June 2012

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Jun 1, 2012

There are no references for this article.